REG - Spire Healthcare Grp - Director/PDMR Shareholding

Spire HealthcareAnnouncement

14/03/2025 15:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250314:nRSN7952Aa&default-theme=true

RNS Number : 7952A  Spire Healthcare Group PLC  14 March 2025

Spire Healthcare Group plc

14 March 2025

 

Notification of Transactions of Persons Discharging Managerial
Responsibilities

 

Grant of Deferred Share Bonus Plan (DSBP) Awards

Spire Healthcare Group plc (the Company) announces that on 13 March 2025,
awards (the DSBP Awards) were granted over the Company's ordinary shares in
the form of nil-cost options to the Directors named below, under the Company's
DSBP.

 

Under the DSBP, Executive Directors are required to defer a proportion of
their gross bonus, received in respect of the financial year ended 31 December
2024, into shares in the Company for a period of three years. The Directors
listed below have the following interest in shares as deferred share bonus
awards under the DSBP:

 

 Director       Percentage deferral of 2024 gross bonus*  Deferred Shares
 Justin Ash     33%                                       65,896
 Harbant Samra  33%                                       24,730

* To be disclosed in the 2024 Annual Report and Accounts

The share price used to determine the number of Deferred Shares subject to
award was 176.0 pence, being the mid-market closing share price on 12 March
2025 (the dealing day prior to the awards being made).

The DSBP Awards will vest on the third anniversary of the grant date on 13
March 2028.

The transaction place is London.

Name of contact for queries:

Amie
Gramlick
investors@spirehealthcare.com

Director of Investor Relations

Spire Healthcare Group plc

 

 

Notification and public disclosure of transaction by persons discharging
managerial responsibility and persons closely associated with them

 

 1   Details of the person discharging managerial responsibilities/person closely
     associated
 a)  Name                                                         Justin Ash

 2   Reason for the notification
 a)  Position/status                                              Chief Executive Officer/PDMR

 b)  Initial notification /Amendment                              Initial notification

 3   Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                                         Spire Healthcare Group plc

 b)  LEI                                                          213800IBJPW3SE2RA350

 4   Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument  Ordinary shares of 1 pence each

     Identification code

                                                                  GB00BNLPYF73
 b)  Nature of the transaction                                    Grant of performance share awards under the Company's Deferred Share Bonus
                                                                  Plan
 c)  Price(s) and volume(s)                                       Price(s)                                Volume(s)
     Nil                                                                                                  65,896

 d)  Aggregated information                                       As above

     - Aggregated volume

     - Price
 e)  Date of the transaction                                      2025-03-13
 f)  Place of the transaction                                     XLON

 

 

 1   Details of the person discharging managerial responsibilities/person closely
     associated
 a)  Name                                                         Harbant Samra

 2   Reason for the notification
 a)  Position/status                                              Chief Financial Officer/PDMR

 b)  Initial notification /Amendment                              Initial notification

 3   Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                                         Spire Healthcare Group plc

 b)  LEI                                                          213800IBJPW3SE2RA350

 4   Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument  Ordinary shares of 1 pence each

     Identification code

                                                                  GB00BNLPYF73
 b)  Nature of the transaction                                    Grant of performance share awards under the Company's Deferred Share Bonus
                                                                  Plan
 c)  Price(s) and volume(s)                                       Price(s)                                Volume(s)
     Nil                                                                                                  24,730

 d)  Aggregated information                                       As above

     - Aggregated volume

     - Price
 e)  Date of the transaction                                      2025-03-13
 f)  Place of the transaction                                     XLON

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHBSGDXUSBDGUS